Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 8,570.50
+270.50 (3.26%)
Aug 11, 2026, 3:15 PM IST
Divi's Laboratories Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Divi's Laboratories stock has a consensus rating of "Hold" and an average price target of ₹8,260. The average 1-year stock price forecast is 3.62% lower than the current stock price, while the lowest is ₹6,000 (-29.99%) and the highest is ₹11,700 (+36.51%).
Price Target: ₹8,260 (-3.62%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Divi's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 10 | 10 | 10 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 5 | 6 | 6 | 6 | 6 | 6 |
| Sell | 7 | 8 | 6 | 6 | 6 | 5 |
| Strong Sell | 4 | 2 | 3 | 3 | 3 | 4 |
| Total | 31 | 31 | 30 | 30 | 30 | 30 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains ₹9,100 | Buy | Maintains | ₹9,100 | +6.18% | Aug 4, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Upgrades ₹8,035 | Buy | Upgrades | ₹8,035 | -6.25% | May 29, 2026 |
Financial Forecast
Revenue This Year
125.66B
from 105.60B
Increased by 19.00%
Revenue Next Year
149.89B
from 125.66B
Increased by 19.28%
EPS This Year
122.96
from 98.86
Increased by 24.37%
EPS Next Year
150.33
from 122.96
Increased by 22.26%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.